 FOSTER CITY, Calif., March 22, 2021 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that it will report financial results for the fourth quarter and full year 2020 after market close on March 29, 2021. Company management will host a conference call and webcast beginning at 4:30 p.m. ET 1:30 p.m. PT that day to discuss the financial results and provide a business update. 